Effect of an Early Dose of Measles Vaccine on Morbidity Between 18 Weeks and 9 Months of Age: A Randomized, Controlled Trial in Guinea-Bissau

BACKGROUND: Children in Guinea-Bissau receive measles vaccine (MV) at 9 months of age, but studies have shown that an additional dose before 9 months of age might have beneficial nonspecific effects. Within a randomized trial designed to examine nonspecific effects of early MV receipt on mortality,...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Infect Dis
Auteurs principaux: Do, Vu An, Biering-Sørensen, Sofie, Fisker, Ane Bærent, Balé, Carlito, Rasmussen, Stine Møller, Christensen, Lone Damkjær, Jensen, Kristoffer Jarlov, Martins, Cesário, Aaby, Peter, Benn, Christine Stabell
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2017
Sujets:
Major Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5441109/
https://ncbi.nlm.nih.gov/pubmed/28077730
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiw512
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires